Clinical Trials Directory

Trials / Completed

CompletedNCT02727270

Measuring Cortisol Levels in Persons With Parkinson's (PD)

Status
Completed
Phase
Study type
Observational
Enrollment
131 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to evaluate the cortisol awakening response with persons with Parkinsons Disease (PD), Huntingtons Disease (HD), and controls. These data are desired so experience can be gained with measuring stress levels subjectively and objectively in persons with PD, HD, and controls.

Detailed description

Telephone consent will be obtained. Participants will collect saliva at twelve time points - four times a day for three days. Visits will be conducted virtually (over the internet). The virtual visit is to assess Parkinson's or Huntington's disease status, stress, mood, and quality of life.

Conditions

Interventions

TypeNameDescription
OTHERNo Intervention - Observational StudyNo Intervention - Observational Study

Timeline

Start date
2016-06-01
Primary completion
2023-11-16
Completion
2023-11-16
First posted
2016-04-04
Last updated
2023-12-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02727270. Inclusion in this directory is not an endorsement.

Measuring Cortisol Levels in Persons With Parkinson's (PD) (NCT02727270) · Clinical Trials Directory